Cite

HARVARD Citation

    Chen, J. et al. (2021). Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC. Cell transplantation. p. . [Online]. 
  
Back to record